Showing 1 to 1 of 1 results
lexpress.fr
🌐 90% Global Worthiness


New Anti-bronchiolitis Drug, Beyfortus, Faces Misinformation Campaign
Ahead of the September 1st launch of a national prevention campaign against respiratory syncytial virus (RSV), a disinformation campaign targeting the new monoclonal antibody Beyfortus has emerged, fueled by concerns about its safety and cost-effectiveness.
New Anti-bronchiolitis Drug, Beyfortus, Faces Misinformation Campaign
Ahead of the September 1st launch of a national prevention campaign against respiratory syncytial virus (RSV), a disinformation campaign targeting the new monoclonal antibody Beyfortus has emerged, fueled by concerns about its safety and cost-effectiveness.
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results